| 9/18/2025 | BKCVIG | Moody's lifts Hercules
|
| 6/12/2025 | BKCVIG | Fitch gives Hercules notes BBB-
|
| 4/15/2025 | BKCVIG | Fitch ups secured debt of 18 companies
|
| 3/10/2025 | CV | Hercules greenshoe lifts 4.75% convertibles to $287.5 million
|
| 3/6/2025 | CV | Market Commentary: Dynavax exchanges; Hercules Capital convertibles struggle on debut; Strategy regains par
|
| 3/6/2025 | CV | Market Commentary: Morning Commentary: Dynavax exchanges; Hercules Capital convertibles struggle on debut
|
| 3/6/2025 | CV | New Issue: Hercules prices $250 million 4.75% convertibles due September 2028 at 98.5, up 12.5%
|
| 3/5/2025 | CV | New Issue: Hercules prices $250 million 4.75% convertibles due September 2028, up 12.5%
|
| 3/5/2025 | CV | Market Commentary: Hercules Capital convertibles prices; Alphatec, KKR notes play to heavy demand
|
| 3/5/2025 | CV | Market Commentary: Morning Commentary: Hercules convertibles on deck; Alphatec, KKR play to heavy demand
|
| 3/5/2025 | CV | Hercules talks $250 million convertibles at 98.5 and coupon of 4.625%-4.875%, up 12.5%-17.5%
|
| 3/5/2025 | CV | Hercules Capital talks $250 million three-year convertibles at 4.625%-4.875%, up 12.5%-17.5%
|
| 4/14/2022 | CV | Fitch revises CIFI outlook to negative
|
| 4/14/2022 | BKCVIGPF | DBRS turns Hercules trend to positive
|
| 4/14/2022 | CVEMGN | Fitch revises CIFI outlook to negative
|
| 2/23/2022 | BKBWCVIGLM | Hercules lowers cost of debt, pushes maturities out to 2024 via refi
|
| 4/20/2021 | BKCVIGPF | DBRS revises Hercules Capital trend to stable
|
| 3/5/2021 | BKCVPF | Moody's assigns Hercules Capital Baa3
|
| 9/25/2018 | BKCVIGPF | DBRS rates Hercules notes BBB
|
| 9/7/2018 | BKCVHYIGPF | DBRS rates Hercules Capital debt BBB
|
| 9/5/2018 | BKCVHYIGPF | S&P drops Hercules Capital to junk
|
| 4/24/2018 | BKCVIGPF | S&P rates Hercules Capital notes BBB-
|
| 4/3/2018 | BKCVHYIG | S&P acts on business development companies
|
| 10/19/2017 | CVIGPF | S&P rates Hercules Capital notes BBB-
|
| 7/31/2017 | CV | Market Commentary: Intercept Pharmaceuticals topical on results, trial data; Hercules Capital unchanged
|
| 7/31/2017 | CV | Market Commentary: Morning Commentary: Hercules Capital trades flat ahead of earnings; Trinity Industries eyed
|
| 1/25/2017 | CV | Hercules greenshoe exercised, ups convertibles to $230 million
|
| 1/23/2017 | BKCVPF | S&P rates Hercules Capital convertibles BBB-
|
| 1/20/2017 | CV | Market Commentary: Liberty Media, Hercules trade over par post-pricing on ‘good volume’; Herbalife active
|
| 1/20/2017 | CV | Market Commentary: Morning Commentary: Liberty Media, Hercules over par post-pricing; market sees ‘good volume’
|
| 1/19/2017 | CV | New Issue: Hercules prices upsized $200 million convertibles to yield 4.375%, up 15%
|
| 1/19/2017 | CV | Market Commentary: Market awaits new deals from Hercules, Liberty; Nabors in focus; Finisar convertibles firm
|
| 1/19/2017 | CV | Market Commentary: Morning Commentary: Market awaits new deals from Hercules, Liberty; Nabors remains in focus
|
| 1/18/2017 | CV | Market Commentary: Convertible bond market muted; New York Mortgage prices; Hercules Capital on tap
|
| 1/18/2017 | CV | Hercules to price $150 million five-year convertibles to yield 4.25%-4.5%, up 12.5%-17.5%
|
